Cargando…
Metabolomics Provides Insights into Renoprotective Effects of Semaglutide in Obese Mice
PURPOSE: Semaglutide, a new long-acting glucagon-like peptide-1 analogue, has shown benefits for renal diseases, but its direct role on kidney metabolism under obesity remains unclear. The study aims to elucidate the protective effect and metabolic modulation mechanism of semaglutide on obesity-rela...
Autores principales: | Chen, Xing, Chen, Shuchun, Ren, Qingjuan, Niu, Shu, Pan, Xiaoyu, Yue, Lin, Li, Zelin, Zhu, Ruiyi, Jia, Zhuoya, Chen, Xiaoyi, Zhen, Ruoxi, Ban, Jiangli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656502/ https://www.ncbi.nlm.nih.gov/pubmed/36388084 http://dx.doi.org/10.2147/DDDT.S383537 |
Ejemplares similares
-
Effect of semaglutide and empagliflozin on cognitive function and hippocampal phosphoproteomic in obese mice
por: Chen, Xiaoyi, et al.
Publicado: (2023) -
UTP14A, DKC1, DDX10, PinX1, and ESF1 Modulate Cardiac Angiogenesis Leading to Obesity-Induced Cardiac Injury
por: Pan, Xiaoyu, et al.
Publicado: (2022) -
Effect of high-fat diet and empagliflozin on cardiac proteins in mice
por: Pan, Xiaoyu, et al.
Publicado: (2022) -
Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model
por: Niu, Shu, et al.
Publicado: (2022) -
Effects of semaglutide on vascular structure and proteomics in high-fat diet-induced obese mice
por: Yue, Lin, et al.
Publicado: (2022)